EGFL8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.883400E-01
Normal-vs-Stage2
8.007600E-01
Normal-vs-Stage3
3.195000E-01
Normal-vs-Stage4
9.536400E-01
Stage1-vs-Stage2
8.073600E-01
Stage1-vs-Stage3
4.990200E-02
Stage1-vs-Stage4
8.497600E-01
Stage2-vs-Stage3
2.559200E-01
Stage2-vs-Stage4
8.741000E-01
Stage3-vs-Stage4
6.035000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.127000E-01
Normal-vs-AfricanAmerican
5.207800E-01
Normal-vs-Asian
5.004600E-01
Caucasian-vs-AfricanAmerican
2.958400E-01
Caucasian-vs-Asian
5.556600E-01
AfricanAmerican-vs-Asian
1.605390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.650800E-01
Normal-vs-Female
7.022600E-01
Male-vs-Female
8.134400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.576800E-01
Normal-vs-Age(41-60Yrs)
7.683800E-01
Normal-vs-Age(61-80Yrs)
7.307800E-01
Normal-vs-Age(81-100Yrs)
6.165000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.556800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.918200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.889000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.470000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.366400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.358800E-01
Normal-vs-Daily Drinker
7.458000E-01
Normal-vs-Weekly Drinker
3.416400E-01
Normal-vs-Occasional Drinker
8.643600E-01
Normal-vs-Social Drinker
8.170000E-01
Non Drinker-vs-Daily Drinker
7.774200E-01
Non Drinker-vs-Weekly Drinker
1.951370E-01
Non Drinker-vs-Occasional Drinker
2.001000E-01
Non Drinker-vs-Social Drinker
6.369000E-01
Daily Drinker-vs-Weekly Drinker
1.635180E-01
Daily Drinker-vs-Occasional Drinker
3.472000E-01
Daily Drinker-vs-Social Drinker
8.421800E-01
Weekly Drinker-vs-Occasional Drinker
3.772000E-02
Weekly Drinker-vs-Social Drinker
1.479950E-01
Occasional Drinker-vs-Social Drinker
4.847400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.825400E-01
Normal-vs-Grade 2
5.912000E-01
Normal-vs-Grade 3
8.463200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.613600E-01
Grade 1-vs-Grade 3
2.225200E-01
Grade 1-vs-Grade 4
6.825400E-01
Grade 2-vs-Grade 3
9.872300E-02
Grade 2-vs-Grade 4
5.912000E-01
Grade 3-vs-Grade 4
8.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.898800E-01
Normal-vs-NonDiabetic
6.356000E-01
Diabetic-vs-NonDiabetic
5.479600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.859000E-01
Normal-vs-NoPancreatitis
7.561200E-01
Pancreatitis-vs-NoPancreatitis
3.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.021000E-01
Normal-vs-N1
7.701800E-01
N0-vs-N1
4.007600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.661200E-01
Normal-vs-TP53-NonMutant
6.358800E-01
TP53-Mutant-vs-TP53-NonMutant
1.856410E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
